Dynamics of high residual platelet reactivity in patients with myocardial infarction in thrombolytic therapy
https://doi.org/10.51922/2616-633X.2021.5.2.1321
Abstract
The aim of the study was to assess the incidence of high residual platelet reactivity in patients with myocardial infarction (MI), depending on the age and reperfusion therapy at different times from the onset of MI. Conclusion. The study revealed a high percentage of patients with MI with an insufficient response to acetylsalicylic acid and clopidogrel at different times from the onset of MI. There were no differences in the indicators of the aggregatogram depending on the age of the patients. There were no differences in the indicators of the aggregatogram depending on the type of reperfusion therapy performed (only TLT or TLT + PCI). There were no differences in the indicators of the aggregatogram depending on the type of implanted stents.
About the Authors
T. Pronko
Grodno State Medical University
Belarus
Belarus
V. Snezhitskiy
Grodno State Medical University
Belarus
Belarus
A. Kapytski
Grodno State Medical University
Belarus
Belarus
References
1. Ibanez B., James S., Agewall S., Antunes M., Bucciarelli-Ducci Ch., Bueno H., Caforio A., Crea F., Goudevenos J., Halvorsen S., Hindricks G., Kastrati A., Lenzen M. J, Prescott E., Roffi M., Valgimigli M., Varenhorst C., Vranckx P., Widimský P. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J, 2018, vol. 39 no. 2, pp. 119-177. doi: 10.1093/eurheartj/ehx393.
2. Ostrowska M., Kubica J., Adamski P., Kubica A., Eyileten C., Postula M., Toma A., Hengsten-berg C., Siller-Matula J. M. Stratified Approaches to Antiplatelet Therapies Based on Platelet Reactivity Testing. Front. Cardiovasc. Med, 2019, vol. 6, pp. 176. doi: 10.3389/fcvm.2019.00176.
3. Snoep J. D., Hovens M. M., Eikenboom J. C., van der Bom J. G., Huisman M.V. Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and metaanalysis. Archives of Internal Medicine, 2007, vol. 167, no. 15, pp. 1593-1599. doi:10.1001/archinte.167.15.1593.
4. Warlo E. M. K., Arnesen H., Seljeflot I. A brief review on resistance to P2Y 12 receptor antagonism in coronary artery disease. Thromb J, 2019, vol. 17, no. 11, pp. 2-9. doi: 10.1186/s12959-019-0197-5.
5. Calatzis A., Loreth R., Spannagl M. Multiplate® platelet function analysis - application and interpretation. Verum Diagnostica GmbH, 2007, pp. 1-35.
6. Ogurcov P. P., Kochetov A. G., Ljang O. V., Politidis R. R., Dzhappuev A. D. Diagnostika agregacionnoj aspirinorezistentnosti u bolnyh s perenesennym infarktom miokarda pri vtorichnoj profilaktike tromboticheskih oslozhnenij [Diagnostics of aggregation aspirin resistance in patients with myocardial infarction with secondary prevention of thrombotic complications]. Vestnik RUDN, 2012, no. 2, pp. 116-121. (in Russian).
7. Barinov Je. F, Sulaeva O. N., Kireeva M. A. Dinamika agregacii trombocitov u pacientov s ostrym infarktom miokarda na fone patogeneticheskoj terapii [Dynamics of platelet aggregation in patients with acute myocardial infarction under pathogenetic therapy]. Vestnik problem biologii i mediciny, 2012, vol. 1, no. 2, pp. 29-31. (in Russian).
8. Grinshtejn I. Ju., Savchenko A. A., Grinshtejn Ju. I., Shimohina N. Ju., Petrova M. M., Gvozdev I. I. Dinamika izmenenij gemostaza i funkcional’noj aktivnosti nejtrofilov u pacientov s raznoj chuvstvitel’nost’ju k acetilsalicilovoj kislote pri ostrom infarkte miokarda [Dynamics of changes in hemostasis and functional activity of neutrophils in patients with different sensitivity to acetylsalicylic acid in acute myocardial in-farction]. Rossijskij kardiologicheskij zhurnal, 2016, no. 8, pp. 36-41. (in Russian).
9. Winter M. P., Schneeweiss T., Cremer R., Biesinger B., Hengstenberg C., Prüller F., Wallner M., Kolesnik E., von Lewinski D., Lang I. M., Siller-Matula J. M. Platelet reactivity patterns in patients treated with dual antiplatelet therapy. Eur J Clin Invest, 2019, vol. 49, no. 6, pp. e13102. doi: 10.1111/eci.13102.
10. Poloneckij L. Z., Denisevich T. L., Mironchik V. V., Nedorezov V. L., Latyshev S. I., Truhan O. A. Vliyanie tromboliticheskoj terapii streptokinazoj v sochetanii s alprostadilom na dinamiku pokazatelej gemostaza i reperfuzii u bol’nyh ostrym infarktom miokarda [Effect of thrombolytic therapy with streptokinase in combination with alprostadil on the dynamics of hemostasis and reperfusion parameters in patients with acute myocardial infarction]. Mezhdunarodnye obzory: klinicheskaya praktika i zdorov’e, 2013, no. 5, pp. 11-20. (in Russian).
11. Amin A. M., Chin L. Sh., Noor D., Kader A., Hay Y. K., Ibrahim B. The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics. Cardiology Research and Practice, 2017, vol. 2, pp. 17. doi: 10.1155/2017/8062796.
12. Wurtz M. Aspirin in Coronary Artery Disease. An Appraisal of Functions and Limitations. Danish Medical Journal, 2015, vol. 62, no. 4, pp. B5011.
Review
For citations:
Pronko T., Snezhitskiy V., Kapytski A. Dynamics of high residual platelet reactivity in patients with myocardial infarction in thrombolytic therapy. Emergency Cardiology and Cardiovascular Risks journal. 2021;5(2):1321–1328. (In Russ.) https://doi.org/10.51922/2616-633X.2021.5.2.1321
Views:
25
Email this article 